# Gateway for Cancer Research

Source: https://onco.cc/institutions/gateway-for-cancer-research/  
OnCo record `gateway-for-cancer-research` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A US charity, founded in 1991, that funds only early-phase (phase I and II) clinical trials of new cancer treatments, for cancers of all types.

## Summary

Gateway for Cancer Research was founded in 1991 and describes itself as one of the only nonprofits solely dedicated to funding phase I and II clinical trials for cancers of all types, according to its about page. It states that it has supported more than 254 clinical trials and funded over $126 million in research since 1991, that more than 10,000 patients have taken part in trials it funded, and that all donations directly fund early-phase clinical research. Trials in OnCo that name it as a funder include a Cedars-Sinai study of ivermectin with immunotherapy in triple-negative breast cancer. The IRS Business Master File lists revenue of about $10 million for the tax year ending June 2025.

## Fields

- Kind: Institution
- Last checked: 2026-11-04
- Also known as: Gateway for Cancer Research Inc
- City: Chicago, IL, US
- Type: consortium
- Website: https://gatewaycr.org

## Sources

- About Gateway for Cancer Research: https://gatewaycr.org/about/
- Gateway for Cancer Research home page: https://gatewaycr.org/
- IRS record (via ProPublica Nonprofit Explorer): https://projects.propublica.org/nonprofits/organizations/731386920

## Connected records

- trials: [Ivermectin with balstilimab or pembrolizumab in metastatic triple-negative breast cancer (Cedars-Sinai phase 1/2)](https://onco.cc/trials/nct05318469/)

---
JSON: https://onco.cc/api/v1/entities/gateway-for-cancer-research.json